Furthermore, as has also been investigated for RA-FLS cells, the combined effect of SIRT1-shRNA the treatment seemed to have higher outcomes (almost 30%) regarding the apoptosis rate compared to each treatment alone (apoptosis rate for silibinin 100 μΜ or SIRT1-shRNA were approximately 10%–15%). Here, SIRT1 is linked to rheumatoid arthritis.